Logo for bioAffinity Technologies Inc

bioAffinity Technologies Investor Relations Material

Latest events

Logo for bioAffinity Technologies Inc

Status Update

bioAffinity Technologies
Logo for bioAffinity Technologies

Q3 2024

14 Nov, 2024
Logo for bioAffinity Technologies

Q2 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from bioAffinity Technologies Inc

Access all reports
bioAffinity Technologies Inc. is a biotechnology company focused on addressing the critical need for non-invasive, early-stage cancer diagnosis and targeted cancer treatments. The company's flagship product, CyPath Lung, is a diagnostic test for the early detection of lung cancer. Additionally, the company is involved in research and development efforts aimed at creating targeted diagnostics and therapeutics to combat cancer, leveraging its core porphyrin platform technology. The company is headquartered in is headquartered in San Antonio, Texas, and its shares are listed on the Nasdaq.